Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic acquires Biophan MRI safety technology:

This article was originally published in Clinica

Executive Summary

Medtronic has acquired magnetic resonance imaging (MRI) safety patents from Biophan Technologies in a deal worth $11m. The acquisition, expected to close within 60 days, will see Medtronic purchase patents covering technologies that can make devices such as pacemakers safe for use with MRI, which can disrupt pacemakers because of the effect of the magnetic fields generated. Medtronic's range of pacemakers includes the EnPulse, EnRhythm and AT500 pacing systems, and the Kappa and Sigma product lines. Established in 2000, Pittsford, New York-based Biophan holds around 61 issued US patents and over 100 pending applications at various stages of examination. It will continue to work on the development of technologies to enable visualisation of clotting and restenosis in stents under MRI, a procedure which is not possible with current stents. The company will also continue its collaboration with its business partner Myotech, which aims to produce the Myotech circulatory support system, a device for the treatment of acute heart failure (see Clinica No 1215, p 21).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049434

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel